HSI1 23,508.17 0.00 --
HSCEI1 7,904.37 0.00 --
Back    Zoom +    Zoom - Block Traded
UBS: China Stocks' Risk-Reward to Improve in 2027; Maintains Barbell Strategy Favoring AI Hardware and Bank Stocks; HSI TP at 26,000 by End-2027
2026-11-17 13:53:22
UBS published a research report stating that it expects stronger performance for China equities in 2027, as MSCI China has already fallen 18% year to date, improving the risk-reward profile. The bank set its end-2027 target for MSCI China at 76, implying around 13% upside, and forecast 2027 EPS growth of 10%. Its end-2027 target for the HSI is 26,000, implying 10% upside, with projected 2027 EPS growth of 8%.

The bank noted that supporting factors include reduced earnings drag from food delivery competition and RMB appreciation, which are estimated to contribute an additional 4% to 5% to 2027 EPS growth; significantly lowered expectations for tech stocks, with the STAR 50 Index and ChiNext retreating more than 40% from their peaks; and continued government support for stable economic and equity market growth. Key catalysts include breakthroughs in mass production of key AI components such as HBM, capital expenditure guidance from US hyperscale cloud operators exceeding market concerns, stabilization in home prices driving activity improvement, and improving earnings trends in 1Q27.

The bank maintained its barbell strategy, with core allocations to AI tech hardware, banks and selected internet stocks, while also allocating part of the portfolio to oversold outbound expansion-related stocks, which are expected to perform better from 2Q27 onward. The bank is most cautious on automakers and consumer stocks.

UBS added BeOne Medicines Ltd. (ONC.US) and JD.com, Inc. (JD.US) to its most recommended model portfolio, while removing BYD COMPANY (01211.HK) and BIDU-W (09888.HK).


UBS Most Recommended Model Portfolio:
Stock | Investment Rating | TP
FUYAO GLASS (03606.HK) | Buy | HKD75.29
ZIJIN MIN-500 (02899.HK) | Buy | HKD56
NAURA (002371.SZ) | Buy | RMB905
TENCENT (00700.HK) | Buy | HKD742.6
CONTEMPORARY AMPEREX (300750.SZ) | Buy | RMB520
SYTECH (600183.SH) | Buy | RMB209
Alibaba Group Holding Limited (BABA.US) | Buy | USD207.15
CNOOC (00883.HK) | Buy | HKD34.3
ZIJIN GOLD INTL (02259.HK) | Buy | HKD195.9
KEDALI (002850.SZ) | Buy | RMB255
BANK OF JIANGSU (600919.SH) | Buy | RMB14
CCB (00939.HK) | Buy | HKD12.01
SMIC (00981.HK) | Buy | HKD102.3
CXMT (688825.SH) | Buy | RMB76
癒簞BeOne Medicines Ltd. (ONC.US) | Buy | USD529
癒簞JD.com, Inc. (JD.US) | Buy | USD48.17

癒簞Newly Added

(da/u)~

AASTOCKS Financial News
Website: www.aastocks.com


This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.